Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Basic information
- Product Name:
- Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
- Synonyms:
-
- Cyclizine dihydrochloride
- Piperazine, 1-benzhydryl-4-methyl-, dihydrochloride
- Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride
- 1-Diphenylmethyl-4-methylpiperazine dihydrochloride
- Cyclizine 2HCl
- Piperazine, 1-(diphenylmethyl)-4-methyl-, hydrochloride (1:2)
- Cyclizine 2hydrochloride
- Marzine hydrochloride
- CAS:
- 5897-18-7
- MF:
- C18H24Cl2N2
- MW:
- 339.30256
- Mol File:
- 5897-18-7.mol
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Chemical Properties
- storage temp.
- Inert atmosphere,Store in freezer, under -20°C
- solubility
- Soluble in DMSO > 10 mM
- form
- Powder
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride Usage And Synthesis
Uses
Cyclizine dihydrochloride, a piperazine-derivative, is a potent and selective histamine H1 receptor antagonist. Cyclizine dihydrochloride can be used for the research of nausea, vomiting, and dizziness[1][2][3].
Biological Activity
Cyclizine 2HCl is a piperazine derivative with Histamine H1 receptor antagonist activity.
in vitro
Cyclizine is a piperazine histamine H1 receptor antagonist and has anticholinergic and antiemetic properties. It increases lower esophageal sphincter tone and reduces the sensitivity of tortuous organs.
in vivo
Cyclizine is metabolized to its N-desmethyl derivative, Norcyclizine, which has little antihistamine (H1) activity compared to Cyclizine. After oral administration of Cyclizine, the effect will be produced within 30 minutes, and the maximum effect will be achieved within 1-2 hours, which can last for 4-6 hours. Cyclizine administered orally at a dose of 50 mg alone in healthy adult volunteers produced peak plasma concentrations of approximately 70 ng/mL two hours after dosing. The plasma elimination half-life is about 20 hours.
target
| Target | Value |
| Histamine H1 receptor |
IC 50
H1 Receptor
References
[1] Králová J, et, al. The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity. Int Immunopharmacol. 2009 Jul;9(7-8):990-5. DOI:10.1016/j.intimp.2009.04.005
[2] Church MK, et, al. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol. 1980 Aug;69(4):663-7. DOI:10.1111/j.1476-5381.1980.tb07919.x
[3] Leza JC, et, al. Effects of antihistaminics on locomotor activity in mice. Comparison with opiate and amphetamine-induced hyperactivity. Gen Pharmacol. 1991;22(2):293-6. DOI:10.1016/0306-3623(91)90451-b
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochlorideSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 020-31155029 18902330969
- sales@tomums.cn
- Tel
- +1-708-310-1919 +1-13798911105
- sales@invivochem.cn
- Tel
- +86-29-89586680 +86-15129568250
- 1026@dideu.com
- Tel
- 021-38015121 18438616290
- lanwu@univ-bio.com